Cargando…

Development and validation of machine learning-based risk prediction models of oral squamous cell carcinoma using salivary autoantibody biomarkers

INTRODUCTION: The incidence of oral cavity squamous cell carcinoma (OSCC) continues to rise. OSCC is associated with a low average survival rate, and most patients have a poor disease prognosis because of delayed diagnosis. We used machine learning techniques to predict high-risk cases of OSCC by us...

Descripción completa

Detalles Bibliográficos
Autores principales: Tseng, Yi-Ju, Wang, Yi-Cheng, Hsueh, Pei-Chun, Wu, Chih-Ching
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685866/
https://www.ncbi.nlm.nih.gov/pubmed/36424594
http://dx.doi.org/10.1186/s12903-022-02607-2
_version_ 1784835614572544000
author Tseng, Yi-Ju
Wang, Yi-Cheng
Hsueh, Pei-Chun
Wu, Chih-Ching
author_facet Tseng, Yi-Ju
Wang, Yi-Cheng
Hsueh, Pei-Chun
Wu, Chih-Ching
author_sort Tseng, Yi-Ju
collection PubMed
description INTRODUCTION: The incidence of oral cavity squamous cell carcinoma (OSCC) continues to rise. OSCC is associated with a low average survival rate, and most patients have a poor disease prognosis because of delayed diagnosis. We used machine learning techniques to predict high-risk cases of OSCC by using salivary autoantibody levels and demographic and behavioral data. METHODS: We collected the salivary samples of patients recruited from a teaching hospital between September 2008 and December 2012. Ten salivary autoantibodies, sex, age, smoking, alcohol consumption, and betel nut chewing were used to build prediction models for identifying patients with a high risk of OSCC. The machine learning algorithms applied in the study were logistic regression, random forest, support vector machine with the radial basis function kernel, eXtreme Gradient Boosting (XGBoost), and a stacking model. We evaluated the performance of the models by using the area under the receiver operating characteristic curve (AUC), with simulations conducted 100 times. RESULTS: A total of 337 participants were enrolled in this study. The best predictive model was constructed using a stacking algorithm with original forms of age and logarithmic levels of autoantibodies (AUC = 0.795 ± 0.055). Adding autoantibody levels as a data source significantly improved the prediction capability (from 0.698 ± 0.06 to 0.795 ± 0.055, p < 0.001). CONCLUSIONS: We successfully established a prediction model for high-risk cases of OSCC. This model can be applied clinically through an online calculator to provide additional personalized information for OSCC diagnosis, thereby reducing the disease morbidity and mortality rates. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12903-022-02607-2.
format Online
Article
Text
id pubmed-9685866
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-96858662022-11-25 Development and validation of machine learning-based risk prediction models of oral squamous cell carcinoma using salivary autoantibody biomarkers Tseng, Yi-Ju Wang, Yi-Cheng Hsueh, Pei-Chun Wu, Chih-Ching BMC Oral Health Research INTRODUCTION: The incidence of oral cavity squamous cell carcinoma (OSCC) continues to rise. OSCC is associated with a low average survival rate, and most patients have a poor disease prognosis because of delayed diagnosis. We used machine learning techniques to predict high-risk cases of OSCC by using salivary autoantibody levels and demographic and behavioral data. METHODS: We collected the salivary samples of patients recruited from a teaching hospital between September 2008 and December 2012. Ten salivary autoantibodies, sex, age, smoking, alcohol consumption, and betel nut chewing were used to build prediction models for identifying patients with a high risk of OSCC. The machine learning algorithms applied in the study were logistic regression, random forest, support vector machine with the radial basis function kernel, eXtreme Gradient Boosting (XGBoost), and a stacking model. We evaluated the performance of the models by using the area under the receiver operating characteristic curve (AUC), with simulations conducted 100 times. RESULTS: A total of 337 participants were enrolled in this study. The best predictive model was constructed using a stacking algorithm with original forms of age and logarithmic levels of autoantibodies (AUC = 0.795 ± 0.055). Adding autoantibody levels as a data source significantly improved the prediction capability (from 0.698 ± 0.06 to 0.795 ± 0.055, p < 0.001). CONCLUSIONS: We successfully established a prediction model for high-risk cases of OSCC. This model can be applied clinically through an online calculator to provide additional personalized information for OSCC diagnosis, thereby reducing the disease morbidity and mortality rates. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12903-022-02607-2. BioMed Central 2022-11-24 /pmc/articles/PMC9685866/ /pubmed/36424594 http://dx.doi.org/10.1186/s12903-022-02607-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Tseng, Yi-Ju
Wang, Yi-Cheng
Hsueh, Pei-Chun
Wu, Chih-Ching
Development and validation of machine learning-based risk prediction models of oral squamous cell carcinoma using salivary autoantibody biomarkers
title Development and validation of machine learning-based risk prediction models of oral squamous cell carcinoma using salivary autoantibody biomarkers
title_full Development and validation of machine learning-based risk prediction models of oral squamous cell carcinoma using salivary autoantibody biomarkers
title_fullStr Development and validation of machine learning-based risk prediction models of oral squamous cell carcinoma using salivary autoantibody biomarkers
title_full_unstemmed Development and validation of machine learning-based risk prediction models of oral squamous cell carcinoma using salivary autoantibody biomarkers
title_short Development and validation of machine learning-based risk prediction models of oral squamous cell carcinoma using salivary autoantibody biomarkers
title_sort development and validation of machine learning-based risk prediction models of oral squamous cell carcinoma using salivary autoantibody biomarkers
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685866/
https://www.ncbi.nlm.nih.gov/pubmed/36424594
http://dx.doi.org/10.1186/s12903-022-02607-2
work_keys_str_mv AT tsengyiju developmentandvalidationofmachinelearningbasedriskpredictionmodelsoforalsquamouscellcarcinomausingsalivaryautoantibodybiomarkers
AT wangyicheng developmentandvalidationofmachinelearningbasedriskpredictionmodelsoforalsquamouscellcarcinomausingsalivaryautoantibodybiomarkers
AT hsuehpeichun developmentandvalidationofmachinelearningbasedriskpredictionmodelsoforalsquamouscellcarcinomausingsalivaryautoantibodybiomarkers
AT wuchihching developmentandvalidationofmachinelearningbasedriskpredictionmodelsoforalsquamouscellcarcinomausingsalivaryautoantibodybiomarkers